US FDA approves Ultragenyx's gene therapy for rare disorder

The U.S ​Food ‌and Drug ​Administration ​said on Thursday ⁠it ​has ​approved Ultragenyx's gene ​therapy ​for the treatment ‌of ⁠a rare, fatal ​disease.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。